Jens‐Jörg Schnorr
About
In The Last Decade
Jens‐Jörg Schnorr
18 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 65
- Epidemiology 788
- Immunology 546
- Infectious Diseases 420
- Cardiology and Cardiovascular Medicine 209
- Molecular Biology 200
Countries citing papers authored by Jens‐Jörg Schnorr
This map shows the geographic impact of Jens‐Jörg Schnorr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jens‐Jörg Schnorr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jens‐Jörg Schnorr more than expected).
Fields of papers citing papers by Jens‐Jörg Schnorr
This network shows the impact of papers produced by Jens‐Jörg Schnorr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jens‐Jörg Schnorr. The network helps show where Jens‐Jörg Schnorr may publish in the future.
Co-authorship network of co-authors of Jens‐Jörg Schnorr
This figure shows the co-authorship network connecting the top 25 collaborators of Jens‐Jörg Schnorr. A scholar is included among the top collaborators of Jens‐Jörg Schnorr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jens‐Jörg Schnorr. Jens‐Jörg Schnorr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 46 | |
| 2 | 77 | |
| 3 | 23 | |
| 4 | 25 | |
| 5 | 74 | |
| 6 | 44 | |
| 7 | 125 | |
| 8 | 64 | |
| 9 | 1 | |
| 10 | 158 | |
| 11 | 74 | |
| 12 | 46 | |
| 13 | 151 | |
| 14 | Measles virus-induced down-regulation of CD46 is associated with enhanced sensitivity to complement-mediated lysis of infected cells. Eur | 1 |
| 15 | 80 | |
| 16 | 127 | |
| 17 | 4 | |
| 18 | 116 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.